ABVC BioPharma, Inc. (ECOC) Total assets 2018–2025
ABVC BioPharma, Inc. (ECOC) total assets at each fiscal year-end, per SEC filings.
$21.1MFY2025 · since FY2018: $5.9M → $21.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $21.1M | +179.3% |
| FY2024 | $7.5M | -3.1% |
| FY2023 | $7.8M | -18.7% |
| FY2022 | $9.6M | -30.1% |
| FY2021 | $13.7M | +18.0% |
| FY2020 | $11.6M | +67.5% |
| FY2019 | $6.9M | +16.6% |
| FY2018 | $5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross profitECOC Gross marginECOC Operating incomeECOC Operating marginECOC Operating cash flowECOC Free cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total liabilitiesECOC Shareholders’ equityECOC overview →